Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use METHYLPHENIDATE HCl EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for METHYLPHENIDATE HCl EXTENDED-RELEASE CAPSULES. METHYLPHENIDATE HCl extended-release capsules, CII Initial U.S. Approval: 1955
Medication labelWhy this: Advisory · dailymed-prescription
Methylphenidate HCl extended-release capsules are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in pediatric patients 6 to 15 years of age. Limitations of Use The use of methylphenidate HCl extended-release capsules is not recommended in pediatric patients younger than 6 years of age because they had higher plasma exposure and a higher incidence of adverse reactions (e.g., weight loss) than patients 6 years and older at the same dosage [see Warnings and Precautions (5.7), Use in Specific Populations (8.4)].
- generic_name
- methylphenidate hydrochloride
- product_names
- methylphenidate hydrochloride
- ndc
- 0406-1810, 0406-1810-01, 0406-1820, 0406-1820-01, 0406-1830, 0406-1830-01, 0406-1840, 0406-1840-01, 0406-1850, 0406-1850-01, 0406-1860, 0406-1860-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en